Journal of Integrative and Complementary Medicine

Journal of Integrative and Complementary Medicine is a monthly peer-reviewed journal that examines complementary therapies as they are used alongside conventional care, and it has carried its present name since 2022.《整合与补充医学杂志》是一份月刊，研究补充疗法与常规医疗并用时的实际形态，2022 年起使用现名。

Its 2025 Journal Impact Factor is 1.9, the title sits in the third quartile of the integrative and complementary medicine category, and the papers run from randomised trials to guideline documents.2025 年期刊影响因子为 1.9，刊物在该类目居第三四分位，所刊论文从随机对照试验一路排到指南文件。

The readership is made up of clinicians, trialists and health-service researchers, and preference goes to work that a primary care practice or a hospital service could act on.读者由临床医生、试验研究者与卫生服务研究者构成，稿件的取舍偏向基层诊室或医院科室能够据以行动的那一类工作。

Scope

• The scope is integrative medicine as it is practised, complementary approaches examined inside conventional care rather than apart from it, with outcomes framed for health services.范围是实践形态的整合医学，补充疗法被放进常规医疗内部考察，落点放在卫生服务体系用得上的结局上。
• Systematic reviews and meta-analyses form the largest block, 94 and 57 titles among the 650 records deposited since volume 28, and many papers carry both labels.系统综述与荟萃分析是最大的一块，第 28 卷以来入库的 650 条记录里，前者占 94 条，后者占 57 条，两者常落在同一篇里。
• Acupuncture keeps a steady column, 62 titles over the same span, and the papers range from acupressure for symptom clusters to electroacupuncture and sham-controlled designs.针刺保持稳定的一栏，同一区间内有 62 条，稿件从针对症状群的穴位按压，到电针与假针刺对照设计都有。
• Mind and body practice is scattered widely, yoga in 42 titles, mindfulness in 32, tai chi in 11, meditation in 10 and qigong in 6, with the first two far ahead of the rest.身心练习散得很开，瑜伽见 42 条，正念 32 条，太极 11 条，冥想 10 条，气功 6 条，前两类远多于其余几项。
• Pain is the most frequent clinical target at 80 titles, taking in chronic low back pain, headache and migraine, endometriosis and sickle cell disease.疼痛是最常见的临床靶点，相关标题 80 条，慢性腰痛、头痛与偏头痛、子宫内膜异位症与镰状细胞病都有人做。
• Integrative oncology runs through 30 cancer titles and 21 oncology titles, among them joint guidance written with the American Society of Clinical Oncology and nursing papers from a society interest group.整合肿瘤学贯穿 30 条癌症标题与 21 条肿瘤学标题，其中有与美国临床肿瘤学会（American Society of Clinical Oncology）合写的指南，也有学会护理特别兴趣组的文章。
• Manual and body-based work arrives more often as guideline writing than as single trials, chiropractic in 9 titles, massage in 10 and osteopathy once or twice.手法与身体疗法多以指南形态出现，单项试验较少，脊椎按摩 9 条，按摩 10 条，骨病疗法偶有一两条。
• Natural products hold 14 herbal titles and 8 supplement titles, and the same few agents, curcumin, probiotics and immune-support blends, keep returning across volumes.天然药物一侧有 14 条草药标题与 8 条补充剂标题，姜黄素、益生菌与免疫支持配方这几样东西反复出现在不同卷里。
• Traditional systems get separate room, homeopathy in 15 titles, naturopathy in 10, Chinese medicine in 5, and a study of African practice recorded in Akwa Ibom State.传统医学体系各有独立位置，顺势疗法 15 条，自然疗法 10 条，中医 5 条，另有一项来自阿夸伊博姆州的非洲传统医疗研究。
• Method is treated as a subject in itself, 31 titles touching placebo or blinding, and reporting guidance such as the Biofield Therapies checklist for clinical trials.方法本身被当作题目，涉及安慰剂或盲法的标题 31 条，另有生物场疗法临床试验报告清单这一类规范文件。
• Health services research keeps a standing place, 7 policy titles and 6 primary care titles, one of them a study of Medicaid referrals for back pain.卫生服务研究占固定位置，政策类 7 条，基层医疗类 6 条，其中一项考察医疗补助计划如何转诊腰痛患者。
• Groups thin on trial evidence are sought out, veterans in 18 titles, pregnant women in 7, children in 5 and older adults in 4, populations this literature reaches less often.试验证据稀薄的群体被专门找出来，退伍军人 18 条，孕产妇 7 条，儿童 5 条，老年人群 4 条，都是这类文献较少触及的人群。
• Workforce and teaching questions are in scope, 8 education titles plus pieces on nursing, pharmacy and licensure, with telehealth studies at 6, a strand that follows how practitioners are trained.人力与教学问题在范围内，教育类 8 条，另有护理、药学与执业许可方面的文章，远程医疗研究 6 条，这条线索追的是从业者如何受训。
• Global policy enters through commentary, on the Delhi Declaration pathway and on how a consensus statement lands inside a national health system, the 2026 pieces the clearest instance.全球政策经评论进入刊物，讨论德里宣言的落地路径，也讨论一份共识文件如何进入某国卫生体系，2026 年那几篇是最清楚的例子。

History

• The journal began in 1995 as The Journal of Alternative and Complementary Medicine, subtitled Research on Paradigm, Practice, and Policy, issued from New York by Mary Ann Liebert.刊物 1995 年以《替代与补充医学杂志》创刊，副题点出范式、实践与政策三个层面，Mary Ann Liebert 在纽约印行。
• Volume 1 carried four issues in 1995 and the rhythm then quickened, bimonthly from 1999, ten a year from 2006, twelve from 2009, the schedule the National Library of Medicine still records.第 1 卷在 1995 年只出四期，此后逐年加频，1999 年改为双月刊，2006 年增至每年十期，2009 年起每年十二期，这一节律在美国国家医学图书馆（National Library of Medicine）的著录里保留至今。
• Growth in those years was steady rather than explosive, and volume 27 closed the old title in December 2021 with 4550 records deposited across twenty-seven volumes.那些年的扩张是稳步的，第 27 卷在 2021 年 12 月为旧刊收尾，二十七个卷次在 Crossref 累计著录 4550 条。
• The rename came with volume 28 in 2022, and the numbering did not restart, so the first year of the new title is the twenty-eighth year of the journal.更名发生在 2022 年的第 28 卷，卷号没有重新起算，新刊的第一年即这份刊物的第二十八年。
• Two identifiers changed at once, the print ISSN moving from 1075-5535 to 2768-3605 and the online ISSN from 1557-7708 to 2768-3613, library catalogues and every new deposit following.两个标识符同时更换，印刷版国际标准连续出版物号由 1075-5535 改为 2768-3605，网络版由 1557-7708 改为 2768-3613，图书馆编目与每一笔新存档从此改用新号。
• The new name puts integrative first and drops alternative from the masthead, a move in vocabulary that matches how the field describes itself in guidelines and in health policy.新刊名把整合放在前面，把替代从刊头撤下，用语上的这一移动与该领域在指南和卫生政策中的自我描述相合。
• Imprint and ownership moved later. Mary Ann Liebert of New Rochelle held the title through 2025, and the National Library of Medicine records Thousand Oaks and SAGE Publications from 2026.出版方的变动来得更晚，新罗谢尔的 Mary Ann Liebert 持有该刊至 2025 年，美国国家医学图书馆的著录自 2026 年起写作千橡市与 SAGE Publications。
• Crossref already files the whole title under SAGE Publications, so the handover shows in the metadata before the volumes themselves catch up.Crossref 已把整份刊物登记在 SAGE Publications 名下，交接先在元数据里露出，卷册随后跟进。
• Monthly publication has held since the rename, twelve numbers in volumes 28, 30 and 31, eleven in volume 29 where issues 6 and 7 were combined, and two supplements in 2023.更名之后一直按月出版，第 28 卷、第 30 卷与第 31 卷各十二期，2023 年的第 29 卷出了十一期并把 6 期与 7 期合号，同年另有两期增刊。
• Output per volume runs between 97 and 142 deposited items, 650 in all since the rename, against 55 citable items a year in the Journal Citation Reports.每卷入库条目在 97 条至 142 条之间，更名以来合计 650 条，期刊引证报告给出的年可引文献数为 55 篇，差额落在来信、更正与前置材料上。
• The impact factor has climbed slowly, 1.3 in 2023, 1.7 in 2024 and 1.9 in 2025, with a five-year figure of 2.1 and a Journal Citation Indicator of 0.42.影响因子缓慢上行，2023 年为 1.3，2024 年为 1.7，2025 年为 1.9，五年影响因子 2.1，期刊引证指标 0.42，类目百分位 42.7。
• Citations total 707 with a cited half-life of 2.7 years, and gold open access covers 11.8 per cent of the papers, the rest sitting behind a subscription.总被引 707 次，被引半衰期 2.7 年，金色开放获取覆盖 11.8% 的论文，其余仍在订阅墙内。
• Indexing carried over without a break. The old title sat in Index Medicus and MEDLINE from January 1995, and MEDLINE picks the new title up at volume 28, number 1.索引收录没有中断，旧刊自 1995 年 1 月起列于《医学索引》与 MEDLINE，新刊由第 28 卷第 1 期接续。
• Clarivate places the title in Science Citation Index Expanded under INTEGRATIVE & COMPLEMENTARY MEDICINE at Q3, ranked 28 of 48 in the 2025 release.Clarivate 把该刊放在科学引文索引扩展版（Science Citation Index Expanded）的整合与补充医学类目，列 Q3，2025 年排名为 48 种刊物中的第 28 位。

Editors

• Editorial practice shows most plainly in the annual list of referees, printed as Acknowledgment of Reviewers in the first issue of every volume since 2022, beside the first research papers of the year.编辑实践最清楚的一处是年度审稿人名单，2022 年以来每卷第 1 期都以审稿人致谢（Acknowledgment of Reviewers）的名义刊出，与当年的首批研究论文并列。
• Five such lists have appeared, covering 2021 through 2025, so the referee corps is public even though individual reports stay confidential, and the practice survived the publisher change.这样的名单已有五份，覆盖 2021 年至 2025 年，审稿人群体因此公开可查，单份评审意见仍旧保密，而这份名单在出版方更换之后照旧刊出。
• The first list under the new name thanked the reviewers of 2021, so the change of title did not break the record of who had read for the journal.改名后的第一份名单致谢的是 2021 年的审稿人，刊名更换没有切断谁为这份刊物审过稿的记录。
• The Rosalind Franklin Society award marks one paper a year by a woman in science or a researcher from an under-represented minority, a scheme the journal took up with volume 28.该刊与罗莎琳德·富兰克林学会（Rosalind Franklin Society）合设年度论文奖，每年选出一篇论文，作者为女性科学工作者或少数群体研究者，奖项自第 28 卷起随刊设立。
• Recipients are announced inside the volumes, the 2022 award in volume 29 number 8, the 2023 award in volume 30 number 9 and the 2024 award in volume 31 number 5, a sequence without gaps.获奖者在卷内公布，2022 年度奖见第 29 卷第 8 期，2023 年度奖见第 30 卷第 9 期，2024 年度奖见第 31 卷第 5 期，奖项设立以来逐年未断。
• Correspondence has a channel of its own. Letters carry that label and the authors of a challenged paper are given a reply, as in the 2026 exchange over cervical arterial pathology.通信另有通道，来信单独标注，被质疑论文的作者可以作答，2026 年围绕颈部动脉病变的那组往还即是如此。
• Clinical practice guidelines are accepted as a genre in themselves, the 2024 paediatric chiropractic guideline running 17 authors through a Delphi consensus, the 2026 headache guideline on the same route.临床实践指南作为一种独立文体被接纳，2024 年那部儿科脊椎按摩指南由 17 位作者经德尔菲共识程序写成，2026 年的头痛指南走的是同一条路。
• Society documents also land here, among them the 2024 overview of the joint guideline from the Society for Integrative Oncology and the American Society of Clinical Oncology.学会文件也落在这里，2024 年那篇综述即介绍整合肿瘤学会（Society for Integrative Oncology）与美国临床肿瘤学会（American Society of Clinical Oncology）的联合指南。
• Reporting standards get space, the 2024 Biofield Therapies paper setting out what a clinical trial of such interventions has to describe for a reader to weigh it.报告规范同样有位置，2024 年那篇生物场疗法文献规定了此类临床试验必须交代哪些内容，读者才掂得出分量。
• Version control is taken seriously, with Correction to notices for slips and a 2022 retraction of a cryotherapy paper on COVID-related smell loss, the retracted text left in place and flagged.版本管理受到重视，勘误以更正条目发出，2022 年还撤回一篇讨论新冠嗅觉丧失的冷疗论文，原文留在库内并加注标记。
• The column set is wide for a title this size, original research, systematic review, narrative review, qualitative study, protocol, guideline, letter and correction each carrying a label.以这样的体量而言栏目铺得很开，原始研究、系统综述、叙述性综述、定性研究、研究方案、指南、来信与更正各自带标签。
• Two supplement issues ran beside the regular numbers of volume 29 in 2023, and the extra pages did not disturb the monthly sequence of the volumes that followed.2023 年第 29 卷在正刊之外另出两期增刊，多出来的篇幅没有打乱此后各卷按月出刊的次序。